nodes	percent_of_prediction	percent_of_DWPC	metapath
Diclofenamide—Blood uric acid increased—Alitretinoin—peripheral nervous system neoplasm	0.0101	0.0101	CcSEcCtD
Diclofenamide—Blood uric acid increased—Vincristine—peripheral nervous system neoplasm	0.00978	0.00978	CcSEcCtD
Diclofenamide—Hyperuricaemia—Cisplatin—peripheral nervous system neoplasm	0.00915	0.00915	CcSEcCtD
Diclofenamide—Hepatic failure—Dactinomycin—peripheral nervous system neoplasm	0.00868	0.00868	CcSEcCtD
Diclofenamide—Blood uric acid increased—Cisplatin—peripheral nervous system neoplasm	0.00865	0.00865	CcSEcCtD
Diclofenamide—Hyperuricaemia—Etoposide—peripheral nervous system neoplasm	0.00838	0.00838	CcSEcCtD
Diclofenamide—Blood uric acid increased—Etoposide—peripheral nervous system neoplasm	0.00792	0.00792	CcSEcCtD
Diclofenamide—Hepatic failure—Vincristine—peripheral nervous system neoplasm	0.00776	0.00776	CcSEcCtD
Diclofenamide—Pollakiuria—Tretinoin—peripheral nervous system neoplasm	0.00762	0.00762	CcSEcCtD
Diclofenamide—Pollakiuria—Isotretinoin—peripheral nervous system neoplasm	0.00762	0.00762	CcSEcCtD
Diclofenamide—Weight decreased—Tretinoin—peripheral nervous system neoplasm	0.00746	0.00746	CcSEcCtD
Diclofenamide—Weight decreased—Isotretinoin—peripheral nervous system neoplasm	0.00746	0.00746	CcSEcCtD
Diclofenamide—Drowsiness—Tretinoin—peripheral nervous system neoplasm	0.00735	0.00735	CcSEcCtD
Diclofenamide—Drowsiness—Isotretinoin—peripheral nervous system neoplasm	0.00735	0.00735	CcSEcCtD
Diclofenamide—Eruption—Epirubicin—peripheral nervous system neoplasm	0.00709	0.00709	CcSEcCtD
Diclofenamide—Agranulocytosis—Tretinoin—peripheral nervous system neoplasm	0.00686	0.00686	CcSEcCtD
Diclofenamide—Agranulocytosis—Isotretinoin—peripheral nervous system neoplasm	0.00686	0.00686	CcSEcCtD
Diclofenamide—Eruption—Doxorubicin—peripheral nervous system neoplasm	0.00656	0.00656	CcSEcCtD
Diclofenamide—Ataxia—Vincristine—peripheral nervous system neoplasm	0.00655	0.00655	CcSEcCtD
Diclofenamide—Tinnitus—Tretinoin—peripheral nervous system neoplasm	0.00616	0.00616	CcSEcCtD
Diclofenamide—Tinnitus—Isotretinoin—peripheral nervous system neoplasm	0.00616	0.00616	CcSEcCtD
Diclofenamide—Pollakiuria—Alitretinoin—peripheral nervous system neoplasm	0.00577	0.00577	CcSEcCtD
Diclofenamide—Weight decreased—Alitretinoin—peripheral nervous system neoplasm	0.00566	0.00566	CcSEcCtD
Diclofenamide—Tension—Tretinoin—peripheral nervous system neoplasm	0.00564	0.00564	CcSEcCtD
Diclofenamide—Tension—Isotretinoin—peripheral nervous system neoplasm	0.00564	0.00564	CcSEcCtD
Diclofenamide—Agranulocytosis—Dactinomycin—peripheral nervous system neoplasm	0.00561	0.00561	CcSEcCtD
Diclofenamide—Hypokalaemia—Cisplatin—peripheral nervous system neoplasm	0.00561	0.00561	CcSEcCtD
Diclofenamide—Nervousness—Isotretinoin—peripheral nervous system neoplasm	0.00558	0.00558	CcSEcCtD
Diclofenamide—Nervousness—Tretinoin—peripheral nervous system neoplasm	0.00558	0.00558	CcSEcCtD
Diclofenamide—Drowsiness—Alitretinoin—peripheral nervous system neoplasm	0.00557	0.00557	CcSEcCtD
Diclofenamide—Weight decreased—Vincristine—peripheral nervous system neoplasm	0.00545	0.00545	CcSEcCtD
Diclofenamide—Tremor—Tretinoin—peripheral nervous system neoplasm	0.00538	0.00538	CcSEcCtD
Diclofenamide—Tremor—Isotretinoin—peripheral nervous system neoplasm	0.00538	0.00538	CcSEcCtD
Diclofenamide—Agranulocytosis—Alitretinoin—peripheral nervous system neoplasm	0.0052	0.0052	CcSEcCtD
Diclofenamide—Leukopenia—Topotecan—peripheral nervous system neoplasm	0.00519	0.00519	CcSEcCtD
Diclofenamide—Leukopenia—Melphalan—peripheral nervous system neoplasm	0.00508	0.00508	CcSEcCtD
Diclofenamide—Confusional state—Tretinoin—peripheral nervous system neoplasm	0.00473	0.00473	CcSEcCtD
Diclofenamide—Confusional state—Isotretinoin—peripheral nervous system neoplasm	0.00473	0.00473	CcSEcCtD
Diclofenamide—Hyperuricaemia—Epirubicin—peripheral nervous system neoplasm	0.0047	0.0047	CcSEcCtD
Diclofenamide—Tinnitus—Alitretinoin—peripheral nervous system neoplasm	0.00467	0.00467	CcSEcCtD
Diclofenamide—Thrombocytopenia—Topotecan—peripheral nervous system neoplasm	0.00463	0.00463	CcSEcCtD
Diclofenamide—Thrombocytopenia—Tretinoin—peripheral nervous system neoplasm	0.00459	0.00459	CcSEcCtD
Diclofenamide—Thrombocytopenia—Isotretinoin—peripheral nervous system neoplasm	0.00459	0.00459	CcSEcCtD
Diclofenamide—Thrombocytopenia—Melphalan—peripheral nervous system neoplasm	0.00453	0.00453	CcSEcCtD
Diclofenamide—Anorexia—Topotecan—peripheral nervous system neoplasm	0.00451	0.00451	CcSEcCtD
Diclofenamide—Anorexia—Tretinoin—peripheral nervous system neoplasm	0.00447	0.00447	CcSEcCtD
Diclofenamide—Anorexia—Isotretinoin—peripheral nervous system neoplasm	0.00447	0.00447	CcSEcCtD
Diclofenamide—Blood uric acid increased—Epirubicin—peripheral nervous system neoplasm	0.00444	0.00444	CcSEcCtD
Diclofenamide—Anorexia—Melphalan—peripheral nervous system neoplasm	0.00441	0.00441	CcSEcCtD
Diclofenamide—Hyperuricaemia—Doxorubicin—peripheral nervous system neoplasm	0.00435	0.00435	CcSEcCtD
Diclofenamide—Tension—Alitretinoin—peripheral nervous system neoplasm	0.00427	0.00427	CcSEcCtD
Diclofenamide—Paraesthesia—Topotecan—peripheral nervous system neoplasm	0.00425	0.00425	CcSEcCtD
Diclofenamide—Nervousness—Alitretinoin—peripheral nervous system neoplasm	0.00423	0.00423	CcSEcCtD
Diclofenamide—Paraesthesia—Tretinoin—peripheral nervous system neoplasm	0.00421	0.00421	CcSEcCtD
Diclofenamide—Paraesthesia—Isotretinoin—peripheral nervous system neoplasm	0.00421	0.00421	CcSEcCtD
Diclofenamide—Leukopenia—Dactinomycin—peripheral nervous system neoplasm	0.00421	0.00421	CcSEcCtD
Diclofenamide—Somnolence—Tretinoin—peripheral nervous system neoplasm	0.00417	0.00417	CcSEcCtD
Diclofenamide—Somnolence—Isotretinoin—peripheral nervous system neoplasm	0.00417	0.00417	CcSEcCtD
Diclofenamide—Dyspepsia—Topotecan—peripheral nervous system neoplasm	0.00416	0.00416	CcSEcCtD
Diclofenamide—Paraesthesia—Melphalan—peripheral nervous system neoplasm	0.00416	0.00416	CcSEcCtD
Diclofenamide—Dyspepsia—Tretinoin—peripheral nervous system neoplasm	0.00413	0.00413	CcSEcCtD
Diclofenamide—Dyspepsia—Isotretinoin—peripheral nervous system neoplasm	0.00413	0.00413	CcSEcCtD
Diclofenamide—Decreased appetite—Topotecan—peripheral nervous system neoplasm	0.00411	0.00411	CcSEcCtD
Diclofenamide—Blood uric acid increased—Doxorubicin—peripheral nervous system neoplasm	0.00411	0.00411	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Topotecan—peripheral nervous system neoplasm	0.00408	0.00408	CcSEcCtD
Diclofenamide—Tremor—Alitretinoin—peripheral nervous system neoplasm	0.00408	0.00408	CcSEcCtD
Diclofenamide—Decreased appetite—Tretinoin—peripheral nervous system neoplasm	0.00408	0.00408	CcSEcCtD
Diclofenamide—Decreased appetite—Isotretinoin—peripheral nervous system neoplasm	0.00408	0.00408	CcSEcCtD
Diclofenamide—Fatigue—Topotecan—peripheral nervous system neoplasm	0.00408	0.00408	CcSEcCtD
Diclofenamide—Dyspepsia—Melphalan—peripheral nervous system neoplasm	0.00408	0.00408	CcSEcCtD
Diclofenamide—Agranulocytosis—Etoposide—peripheral nervous system neoplasm	0.00406	0.00406	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Tretinoin—peripheral nervous system neoplasm	0.00405	0.00405	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Isotretinoin—peripheral nervous system neoplasm	0.00405	0.00405	CcSEcCtD
Diclofenamide—Fatigue—Isotretinoin—peripheral nervous system neoplasm	0.00404	0.00404	CcSEcCtD
Diclofenamide—Fatigue—Tretinoin—peripheral nervous system neoplasm	0.00404	0.00404	CcSEcCtD
Diclofenamide—Constipation—Topotecan—peripheral nervous system neoplasm	0.00404	0.00404	CcSEcCtD
Diclofenamide—Decreased appetite—Melphalan—peripheral nervous system neoplasm	0.00402	0.00402	CcSEcCtD
Diclofenamide—Constipation—Tretinoin—peripheral nervous system neoplasm	0.00401	0.00401	CcSEcCtD
Diclofenamide—Constipation—Isotretinoin—peripheral nervous system neoplasm	0.00401	0.00401	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Melphalan—peripheral nervous system neoplasm	0.004	0.004	CcSEcCtD
Diclofenamide—Fatigue—Melphalan—peripheral nervous system neoplasm	0.00399	0.00399	CcSEcCtD
Diclofenamide—Tinnitus—Cisplatin—peripheral nervous system neoplasm	0.00398	0.00398	CcSEcCtD
Diclofenamide—Feeling abnormal—Topotecan—peripheral nervous system neoplasm	0.0039	0.0039	CcSEcCtD
Diclofenamide—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	0.00387	0.00387	CcSEcCtD
Diclofenamide—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	0.00387	0.00387	CcSEcCtD
Diclofenamide—Leukopenia—Vincristine—peripheral nervous system neoplasm	0.00376	0.00376	CcSEcCtD
Diclofenamide—Thrombocytopenia—Dactinomycin—peripheral nervous system neoplasm	0.00375	0.00375	CcSEcCtD
Diclofenamide—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.00374	0.00374	CcSEcCtD
Diclofenamide—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.00371	0.00371	CcSEcCtD
Diclofenamide—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.00371	0.00371	CcSEcCtD
Diclofenamide—Anorexia—Dactinomycin—peripheral nervous system neoplasm	0.00365	0.00365	CcSEcCtD
Diclofenamide—Confusional state—Alitretinoin—peripheral nervous system neoplasm	0.00358	0.00358	CcSEcCtD
Diclofenamide—Hepatic failure—Epirubicin—peripheral nervous system neoplasm	0.00352	0.00352	CcSEcCtD
Diclofenamide—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	0.00348	0.00348	CcSEcCtD
Diclofenamide—Tremor—Cisplatin—peripheral nervous system neoplasm	0.00348	0.00348	CcSEcCtD
Diclofenamide—Asthenia—Topotecan—peripheral nervous system neoplasm	0.00339	0.00339	CcSEcCtD
Diclofenamide—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.00339	0.00339	CcSEcCtD
Diclofenamide—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.00337	0.00337	CcSEcCtD
Diclofenamide—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.00337	0.00337	CcSEcCtD
Diclofenamide—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.00335	0.00335	CcSEcCtD
Diclofenamide—Pruritus—Topotecan—peripheral nervous system neoplasm	0.00335	0.00335	CcSEcCtD
Diclofenamide—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.00333	0.00333	CcSEcCtD
Diclofenamide—Leukopenia—Cisplatin—peripheral nervous system neoplasm	0.00332	0.00332	CcSEcCtD
Diclofenamide—Asthenia—Melphalan—peripheral nervous system neoplasm	0.00332	0.00332	CcSEcCtD
Diclofenamide—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.00332	0.00332	CcSEcCtD
Diclofenamide—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.00332	0.00332	CcSEcCtD
Diclofenamide—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.00331	0.00331	CcSEcCtD
Diclofenamide—Pruritus—Melphalan—peripheral nervous system neoplasm	0.00328	0.00328	CcSEcCtD
Diclofenamide—Anorexia—Vincristine—peripheral nervous system neoplasm	0.00327	0.00327	CcSEcCtD
Diclofenamide—Hepatic failure—Doxorubicin—peripheral nervous system neoplasm	0.00326	0.00326	CcSEcCtD
Diclofenamide—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.00319	0.00319	CcSEcCtD
Diclofenamide—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.00316	0.00316	CcSEcCtD
Diclofenamide—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.00316	0.00316	CcSEcCtD
Diclofenamide—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.00313	0.00313	CcSEcCtD
Diclofenamide—Dizziness—Topotecan—peripheral nervous system neoplasm	0.00313	0.00313	CcSEcCtD
Diclofenamide—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.0031	0.0031	CcSEcCtD
Diclofenamide—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.0031	0.0031	CcSEcCtD
Diclofenamide—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.00309	0.00309	CcSEcCtD
Diclofenamide—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.00308	0.00308	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.00307	0.00307	CcSEcCtD
Diclofenamide—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.00306	0.00306	CcSEcCtD
Diclofenamide—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.00304	0.00304	CcSEcCtD
Diclofenamide—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.00304	0.00304	CcSEcCtD
Diclofenamide—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.00303	0.00303	CcSEcCtD
Diclofenamide—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00301	0.00301	CcSEcCtD
Diclofenamide—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00298	0.00298	CcSEcCtD
Diclofenamide—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00298	0.00298	CcSEcCtD
Diclofenamide—Rash—Topotecan—peripheral nervous system neoplasm	0.00298	0.00298	CcSEcCtD
Diclofenamide—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.00298	0.00298	CcSEcCtD
Diclofenamide—Ataxia—Epirubicin—peripheral nervous system neoplasm	0.00298	0.00298	CcSEcCtD
Diclofenamide—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.00297	0.00297	CcSEcCtD
Diclofenamide—Headache—Topotecan—peripheral nervous system neoplasm	0.00296	0.00296	CcSEcCtD
Diclofenamide—Rash—Tretinoin—peripheral nervous system neoplasm	0.00296	0.00296	CcSEcCtD
Diclofenamide—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00296	0.00296	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.00296	0.00296	CcSEcCtD
Diclofenamide—Fatigue—Vincristine—peripheral nervous system neoplasm	0.00295	0.00295	CcSEcCtD
Diclofenamide—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00294	0.00294	CcSEcCtD
Diclofenamide—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00294	0.00294	CcSEcCtD
Diclofenamide—Headache—Tretinoin—peripheral nervous system neoplasm	0.00294	0.00294	CcSEcCtD
Diclofenamide—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.00293	0.00293	CcSEcCtD
Diclofenamide—Constipation—Vincristine—peripheral nervous system neoplasm	0.00293	0.00293	CcSEcCtD
Diclofenamide—Rash—Melphalan—peripheral nervous system neoplasm	0.00292	0.00292	CcSEcCtD
Diclofenamide—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.00289	0.00289	CcSEcCtD
Diclofenamide—Hypokalaemia—Epirubicin—peripheral nervous system neoplasm	0.00288	0.00288	CcSEcCtD
Diclofenamide—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.00281	0.00281	CcSEcCtD
Diclofenamide—Nausea—Topotecan—peripheral nervous system neoplasm	0.00281	0.00281	CcSEcCtD
Diclofenamide—Confusional state—Etoposide—peripheral nervous system neoplasm	0.0028	0.0028	CcSEcCtD
Diclofenamide—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00279	0.00279	CcSEcCtD
Diclofenamide—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00279	0.00279	CcSEcCtD
Diclofenamide—Ataxia—Doxorubicin—peripheral nervous system neoplasm	0.00275	0.00275	CcSEcCtD
Diclofenamide—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.00275	0.00275	CcSEcCtD
Diclofenamide—Nausea—Melphalan—peripheral nervous system neoplasm	0.00275	0.00275	CcSEcCtD
Diclofenamide—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.00272	0.00272	CcSEcCtD
Diclofenamide—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.00272	0.00272	CcSEcCtD
Diclofenamide—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.00271	0.00271	CcSEcCtD
Diclofenamide—Hypokalaemia—Doxorubicin—peripheral nervous system neoplasm	0.00267	0.00267	CcSEcCtD
Diclofenamide—Anorexia—Etoposide—peripheral nervous system neoplasm	0.00265	0.00265	CcSEcCtD
Diclofenamide—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.00263	0.00263	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.00262	0.00262	CcSEcCtD
Diclofenamide—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.00255	0.00255	CcSEcCtD
Diclofenamide—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.00253	0.00253	CcSEcCtD
Diclofenamide—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.00252	0.00252	CcSEcCtD
Diclofenamide—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.0025	0.0025	CcSEcCtD
Diclofenamide—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.00249	0.00249	CcSEcCtD
Diclofenamide—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.00247	0.00247	CcSEcCtD
Diclofenamide—Somnolence—Etoposide—peripheral nervous system neoplasm	0.00247	0.00247	CcSEcCtD
Diclofenamide—Asthenia—Vincristine—peripheral nervous system neoplasm	0.00246	0.00246	CcSEcCtD
Diclofenamide—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.00244	0.00244	CcSEcCtD
Diclofenamide—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.00244	0.00244	CcSEcCtD
Diclofenamide—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00242	0.00242	CcSEcCtD
Diclofenamide—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.00241	0.00241	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.0024	0.0024	CcSEcCtD
Diclofenamide—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.00239	0.00239	CcSEcCtD
Diclofenamide—Fatigue—Etoposide—peripheral nervous system neoplasm	0.00239	0.00239	CcSEcCtD
Diclofenamide—Constipation—Etoposide—peripheral nervous system neoplasm	0.00237	0.00237	CcSEcCtD
Diclofenamide—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.00235	0.00235	CcSEcCtD
Diclofenamide—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.00234	0.00234	CcSEcCtD
Diclofenamide—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.00229	0.00229	CcSEcCtD
Diclofenamide—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.00229	0.00229	CcSEcCtD
Diclofenamide—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00228	0.00228	CcSEcCtD
Diclofenamide—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.00228	0.00228	CcSEcCtD
Diclofenamide—Dizziness—Vincristine—peripheral nervous system neoplasm	0.00227	0.00227	CcSEcCtD
Diclofenamide—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.00226	0.00226	CcSEcCtD
Diclofenamide—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.00226	0.00226	CcSEcCtD
Diclofenamide—Rash—Alitretinoin—peripheral nervous system neoplasm	0.00224	0.00224	CcSEcCtD
Diclofenamide—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00223	0.00223	CcSEcCtD
Diclofenamide—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.00219	0.00219	CcSEcCtD
Diclofenamide—Vomiting—Vincristine—peripheral nervous system neoplasm	0.00218	0.00218	CcSEcCtD
Diclofenamide—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.00217	0.00217	CcSEcCtD
Diclofenamide—Rash—Vincristine—peripheral nervous system neoplasm	0.00216	0.00216	CcSEcCtD
Diclofenamide—Headache—Vincristine—peripheral nervous system neoplasm	0.00215	0.00215	CcSEcCtD
Diclofenamide—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00211	0.00211	CcSEcCtD
Diclofenamide—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.00211	0.00211	CcSEcCtD
Diclofenamide—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.00204	0.00204	CcSEcCtD
Diclofenamide—Nausea—Vincristine—peripheral nervous system neoplasm	0.00203	0.00203	CcSEcCtD
Diclofenamide—Asthenia—Etoposide—peripheral nervous system neoplasm	0.00199	0.00199	CcSEcCtD
Diclofenamide—Pruritus—Etoposide—peripheral nervous system neoplasm	0.00196	0.00196	CcSEcCtD
Diclofenamide—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.00193	0.00193	CcSEcCtD
Diclofenamide—Rash—Cisplatin—peripheral nervous system neoplasm	0.00191	0.00191	CcSEcCtD
Diclofenamide—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.00189	0.00189	CcSEcCtD
Diclofenamide—Tension—Epirubicin—peripheral nervous system neoplasm	0.00187	0.00187	CcSEcCtD
Diclofenamide—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.00185	0.00185	CcSEcCtD
Diclofenamide—Dizziness—Etoposide—peripheral nervous system neoplasm	0.00183	0.00183	CcSEcCtD
Diclofenamide—Nausea—Cisplatin—peripheral nervous system neoplasm	0.0018	0.0018	CcSEcCtD
Diclofenamide—Vomiting—Etoposide—peripheral nervous system neoplasm	0.00176	0.00176	CcSEcCtD
Diclofenamide—Rash—Etoposide—peripheral nervous system neoplasm	0.00175	0.00175	CcSEcCtD
Diclofenamide—Headache—Etoposide—peripheral nervous system neoplasm	0.00174	0.00174	CcSEcCtD
Diclofenamide—Tension—Doxorubicin—peripheral nervous system neoplasm	0.00173	0.00173	CcSEcCtD
Diclofenamide—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.00171	0.00171	CcSEcCtD
Diclofenamide—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.00171	0.00171	CcSEcCtD
Diclofenamide—Nausea—Etoposide—peripheral nervous system neoplasm	0.00165	0.00165	CcSEcCtD
Diclofenamide—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.00158	0.00158	CcSEcCtD
Diclofenamide—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.00157	0.00157	CcSEcCtD
Diclofenamide—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.00152	0.00152	CcSEcCtD
Diclofenamide—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.00148	0.00148	CcSEcCtD
Diclofenamide—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.00145	0.00145	CcSEcCtD
Diclofenamide—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.00141	0.00141	CcSEcCtD
Diclofenamide—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.0014	0.0014	CcSEcCtD
Diclofenamide—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.00138	0.00138	CcSEcCtD
Diclofenamide—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.00137	0.00137	CcSEcCtD
Diclofenamide—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.00137	0.00137	CcSEcCtD
Diclofenamide—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.00135	0.00135	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.00134	0.00134	CcSEcCtD
Diclofenamide—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.00134	0.00134	CcSEcCtD
Diclofenamide—Constipation—Epirubicin—peripheral nervous system neoplasm	0.00133	0.00133	CcSEcCtD
Diclofenamide—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.00129	0.00129	CcSEcCtD
Diclofenamide—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.00128	0.00128	CcSEcCtD
Diclofenamide—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.00128	0.00128	CcSEcCtD
Diclofenamide—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.00127	0.00127	CcSEcCtD
Diclofenamide—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.00125	0.00125	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.00124	0.00124	CcSEcCtD
Diclofenamide—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.00124	0.00124	CcSEcCtD
Diclofenamide—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.00123	0.00123	CcSEcCtD
Diclofenamide—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.00123	0.00123	CcSEcCtD
Diclofenamide—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.00119	0.00119	CcSEcCtD
Diclofenamide—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.00114	0.00114	CcSEcCtD
Diclofenamide—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.00112	0.00112	CcSEcCtD
Diclofenamide—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.0011	0.0011	CcSEcCtD
Diclofenamide—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.00103	0.00103	CcSEcCtD
Diclofenamide—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.00103	0.00103	CcSEcCtD
Diclofenamide—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.00102	0.00102	CcSEcCtD
Diclofenamide—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000989	0.000989	CcSEcCtD
Diclofenamide—Rash—Epirubicin—peripheral nervous system neoplasm	0.000981	0.000981	CcSEcCtD
Diclofenamide—Headache—Epirubicin—peripheral nervous system neoplasm	0.000974	0.000974	CcSEcCtD
Diclofenamide—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000952	0.000952	CcSEcCtD
Diclofenamide—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000924	0.000924	CcSEcCtD
Diclofenamide—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000915	0.000915	CcSEcCtD
Diclofenamide—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000907	0.000907	CcSEcCtD
Diclofenamide—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000902	0.000902	CcSEcCtD
Diclofenamide—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000855	0.000855	CcSEcCtD
